ABN Amro Investment Solutions Purchases Shares of 6,794 Revolution Medicines, Inc. $RVMDMarket Beat·5 hours agoRVMD+0.25%JHG0.00%
Revolution Medicines says FDA accepts daraxonrasib NDA for previously treated metastatic pancreatic cancerPUBT·Jul 22 at 03:11 PMRVMD+0.25%
Vertex Pharmaceuticals Incorporated $VRTX Shares Bought by PNC Financial Services Group Inc.Market Beat·1 day ago, 04:04 AMVRTX+0.90%
16:26 ETERAS INVESTOR DEADLINE: Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - HBSSprnewswire·Jul 21 at 03:28 PMERAS-1.19%RVMD+0.25%
Regulatory Momentum for Daraxonrasib and RAS Pipeline Upside Support Charles Zhu’s Buy Rating on RVMD with Unchanged $263 Price TargetTip Ranks·Jul 22 at 04:35 PMRVMD+0.25%
Cytokinetics EVP R&D Malik Fady Ibraham disposes of 3,500 common shares for $282,065PUBT·2 days ago, 03:10 PMCYTK-1.44%
Illumina Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily GainsMarketWatch Automated·2 days ago, 04:24 PMILMN-1.41%
Vertex Pharmaceuticals (VRTX) Stock Trades Below Fair Value After Deal PlansSimplywall·Jul 20 at 08:14 PMVRTX+0.90%CRNX+0.10%
New AI ETF Bets on Healthcare's $9 Trillion Opportunitybenzinga_article·1 day ago, 02:08 PMHLTH-1.06%CYTK-1.44%
Vertex Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To CompetitorsMarketWatch Automated·Jul 22 at 03:36 PMVRTX+0.90%
Hsbc Holdings PLC Makes New Investment in 10x Genomics $TXGMarket Beat·2 days ago, 03:50 AMTXG-3.72%HSBA
Cytokinetics to Announce Second Quarter Results on August 6, 2026Unusual Whales·2 days ago, 03:02 PMCYTK-1.44%
13:41 ET$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRNX, SLP, NCSM, and PASGprnewswire·2 days ago, 12:41 PMPASG+0.82%SLP+5.00%
Illumina Inc. Stock Outperforms Competitors On Strong Trading DayMarketWatch Automated·Jul 21 at 04:23 PMILMN-1.41%
Vertex Pharmaceuticals Inc. Stock Underperforms Monday When Compared To CompetitorsMarketWatch Automated·Jul 20 at 03:37 PMVRTX+0.90%
